Combination Gefitinib and Methotrexate Compared With Methotrexate Alone to Treat Ectopic Pregnancy

医学 甲氨蝶呤 皮疹 耐受性 异位妊娠 吉非替尼 内科学 胃肠病学 不利影响 腹泻 怀孕 癌症 遗传学 生物 表皮生长因子受体
作者
Monika Skubisz,Andrew W. Horne,Terrance G. Johns,Ulrika W. Nilsson,W. Colin Duncan,Euan M. Wallace,Hilary Critchley,Stephen Tong
出处
期刊:Obstetrics & Gynecology [Lippincott Williams & Wilkins]
卷期号:122 (4): 745-751 被引量:37
标识
DOI:10.1097/aog.0b013e3182a14cfb
摘要

In Brief OBJECTIVE: To determine the safety, tolerability, and efficacy of combination gefitinib and methotrexate to treat ectopic pregnancy. METHODS: We performed a phase I, single-arm (nonrandomized), open-label study. Twelve women with ectopic pregnancies were administered methotrexate (50 mg/m2, intramuscular) and 250 mg oral gefitinib in a dose-escalation protocol: one dose (day 1) n=3; three doses (days 1–3) n=3; seven doses (days 1–7) n=6. Efficacy was examined by comparing human chorionic gonadotrophin (hCG) decline and time to resolution with historic controls administered methotrexate only. RESULTS: Common side effects were transient acneiform rash in 67% (8/12) and diarrhea in 42% (5/12) of participants. There was no clinical or biochemical evidence of serious pulmonary, renal, hepatic, or hematologic toxicity. Of six participants with a pretreatment serum hCG level between 1,000 and 3,000 international units/L, hCG levels declined significantly faster than in the control group. Median serum hCG levels by day 7 after treatment were less than one fifth of levels observed among 71 historic controls treated with methotrexate alone (median [interquartile range] hCG in participants 261 [55–1,445] international units/L compared with controls 1,426 [940–2,573]; P=.008). Median time for the ectopic pregnancies to resolve with combination therapy was 34% shorter compared with methotrexate alone (21 days compared with 32 days; P=.018). CONCLUSION: Combination gefitinib and methotrexate has potential as a treatment for ectopic pregnancy but is commonly associated with minor side effects such as transient rash and diarrhea. The treatment requires validation of safety and efficacy in a larger trial. CLINICAL TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, www.anzctr.org, AC'TRN12610000684022. LEVEL OF EVIDENCE: II The combination of gefitinib and methotrexate has potential as a treatment for ectopic pregnancy, although minor side effects are common.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Cynthia完成签到,获得积分10
1秒前
清爽盼秋发布了新的文献求助10
1秒前
wulanshu完成签到,获得积分10
2秒前
daijk完成签到,获得积分10
2秒前
wjl123456完成签到,获得积分10
2秒前
aoyo发布了新的文献求助20
3秒前
暴躁的元灵完成签到,获得积分10
3秒前
Pastime完成签到 ,获得积分10
3秒前
3秒前
脑洞疼应助暖暖采纳,获得10
3秒前
幽默与研完成签到,获得积分10
3秒前
低贱牛马完成签到 ,获得积分10
4秒前
123完成签到 ,获得积分10
4秒前
4秒前
万能图书馆应助lzzj采纳,获得10
4秒前
CYQ完成签到 ,获得积分10
4秒前
小锂电完成签到,获得积分10
5秒前
5秒前
大盘菜完成签到,获得积分10
5秒前
牧青发布了新的文献求助10
6秒前
小白发布了新的文献求助10
6秒前
时尚溪流完成签到,获得积分10
6秒前
Willow完成签到,获得积分0
7秒前
Cynthia发布了新的文献求助10
7秒前
CTT完成签到,获得积分10
7秒前
tyj完成签到,获得积分10
7秒前
忧郁紫翠完成签到,获得积分10
7秒前
李文秀完成签到,获得积分20
7秒前
8秒前
shineshine完成签到 ,获得积分10
8秒前
森森完成签到,获得积分10
8秒前
更好的我完成签到,获得积分10
8秒前
拼搏梦安发布了新的文献求助10
8秒前
嘿嘿完成签到 ,获得积分10
9秒前
把饭拼好给你完成签到 ,获得积分10
9秒前
暖暖完成签到,获得积分10
9秒前
AllenLau1031完成签到,获得积分10
10秒前
呜呜呜啦完成签到,获得积分10
10秒前
飞快的盼易完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The anomeric effect 1000
Principles of town planning: translating concepts to applications 1000
Navigating Normative Orders: Interdisciplinary Perspectives 750
1 Peter and Christ's Descent to the Dead in Its Early Christian Reception 700
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7732586
求助须知:如何正确求助?哪些是违规求助? 9283486
关于积分的说明 20157833
捐赠科研通 7310259
什么是DOI,文献DOI怎么找? 3304181
关于科研通互助平台的介绍 2457045
邀请新用户注册赠送积分活动 2313291